Migraine Disorders

• 

  Subject Areas on Research

  • A Critical Exploration of Migraine as a Health Disparity: the Imperative of an Equity-Oriented, Intersectional Approach. 
  • A Phase I, Open-Label, Single-Dose Safety, Pharmacokinetic, and Tolerability Study of the Sumatriptan Iontophoretic Transdermal System in Adolescent Migraine Patients. 
  • A Qualitative, Systems Thinking Approach to Study Self-Management in Women With Migraine. 
  • A report on my headaches. 
  • ALPK1 missense pathogenic variant in five families leads to ROSAH syndrome, an ocular multisystem autosomal dominant disorder. 
  • Abdominal migraine: prophylactic treatment and follow-up. 
  • Acute Headache in Adults: A Diagnostic Approach. 
  • Agency and structure in the sociology of sickness. 
  • Antiepileptics in migraine prophylaxis: an updated Cochrane review. 
  • Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults. 
  • Assessing acute systemic effects of an inhaled drug with serial echocardiography: a placebo-controlled comparison of inhaled and intravenous dihydroergotamine. 
  • Beyond pain control: Outcome and treatment preferences in pediatric migraine. 
  • Biofeedback as Prophylaxis for Pediatric Migraine: A Meta-analysis. 
  • Burden of illness and satisfaction with care among patients with headache seen in a primary care setting. 
  • Butalbital in the treatment of headache: history, pharmacology, and efficacy. 
  • Case series of four different headache types presenting as tooth pain. 
  • Changing physician knowledge, attitudes, and beliefs about migraine: evaluation of a new educational intervention. 
  • Computer-assisted interview of patients with functional headache. 
  • Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine. 
  • Cost savings in migraine associated with less chest pain on new triptan therapy. 
  • Cranial electrostimulation for headache: meta-analysis. 
  • Craniosacral therapy for migraine: protocol development for an exploratory controlled clinical trial. 
  • Credibility of low-strength static magnet therapy as an attention control intervention for a randomized controlled study of CranioSacral therapy for migraine headaches. 
  • Current status of percutaneous PFO closure. 
  • Development of a Prospective Real-World Data Clinical Registry of Children and Adolescents With Migraine. 
  • Differences in Chinese diagnoses for migraine and tension-type headache: an analysis of the German acupuncture trials (GERAC) for headache. 
  • Differential diagnosis of staring spells in children: a video-EEG study. 
  • Does this patient with headache have a migraine or need neuroimaging? 
  • Effect of telcagepant on spontaneous ischemia in cardiovascular patients in a randomized study. 
  • Elongated styloid process (Eagle's syndrome) causing hemicrania. 
  • Episodic versus Chronic Dizziness: An Analysis of Predictive Factors. 
  • Ergotamine and dihydroergotamine: history, pharmacology, and efficacy. 
  • Evaluating migraineurs' preferences for migraine treatment outcomes using a choice experiment. 
  • Exploration of migraine pain, disability, depressive symptomatology, and coping: a pilot study 
  • Extrapolating Beyond the Data in a Systematic Review of Spinal Manipulation for Nonmusculoskeletal Disorders: A Fall From the Summit. 
  • Facial pain from an elongated styloid process (Eagle's syndrome). 
  • Flunarizine as prophylaxis for episodic migraine: a systematic review with meta-analysis. 
  • Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults. 
  • Gender Differences in Demographic and Health Characteristics of the Million Veteran Program Cohort. 
  • General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial. 
  • Headache Disorders: Does Pain Affect Blood Pressure? 
  • Headache management program improves outcome for chronic headache. 
  • How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physicians. 
  • Intravenous Migraine Treatment in Children and Adolescents. 
  • Meta-analysis of multitreatment studies. 
  • Methodological issues in systematic reviews of headache trials: adapting historical diagnostic classifications and outcome measures to present-day standards. 
  • Migraine and increased risk of developing open angle glaucoma: a population-based cohort study. 
  • Migraine and retinal microvascular abnormalities: the Atherosclerosis Risk in Communities Study. 
  • Migraine during pregnancy. 
  • Migraine headache in patients with Tourette syndrome. 
  • Migraine headaches following mitral valvuloplasty: Koch's postulates finally satisfied? 
  • Migraine therapeutics in adolescents: a systematic analysis and historic perspectives of triptan trials in adolescents. 
  • Migraine with aura susceptibility locus on chromosome 19p13 is distinct from the familial hemiplegic migraine locus. 
  • Migraine. 
  • Migraines during pregnancy linked to stroke and vascular diseases: US population based case-control study. 
  • Modeling choice behavior for new pharmaceutical products. 
  • Neurovascular pains: implications of migraine for the oral and maxillofacial surgeon. 
  • Opioids. 
  • Oral sumatriptan for acute migraine. 
  • Patterns of Migraine Disease in Otolaryngology: A CHEER Network Study. 
  • Persistent posttraumatic headaches and functioning in veterans: Injury type can matter. 
  • Predicting disability and quality of life in a community-based sample of women with migraine headache 
  • Preventing Episodic Migraine With Caloric Vestibular Stimulation: A Randomized Controlled Trial. 
  • Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project). 
  • Prioritizing treatment attributes and their impact on selecting an oral triptan: results from the TRIPSTAR Project. 
  • Prognostic factors, disability, and functional status among patients in a headache specialty practice. 
  • Pupillary dysautonomia and migraine: is Adie's pupil caused by migraine? 
  • Randomized, controlled study of telcagepant in patients with migraine and coronary artery disease. 
  • Refractory calculation-induced idiopathic generalized epilepsy: a case report and review of the literature. 
  • Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort. 
  • Role of Acupuncture in the Treatment or Prevention of Migraine, Tension-Type Headache, or Chronic Headache Disorders. 
  • Significance of minor eye signs in headache of migraine type. 
  • Sumatriptan-induced stroke in sagittal sinus thrombosis. 
  • Symptomatic epidural cerebrospinal fluid collection following lumbar puncture and aneurysm clipping. 
  • TRIPSTAR: prioritizing oral triptan treatment attributes in migraine management. 
  • The Impact of Spinal Manipulation on Migraine Pain and Disability: A Systematic Review and Meta-Analysis. 
  • The anti-migraine component of butterbur extracts, isopetasin, desensitizes peptidergic nociceptors by acting on TRPA1 cation channel. 
  • The appropriate use of neurostimulation: stimulation of the intracranial and extracranial space and head for chronic pain. Neuromodulation Appropriateness Consensus Committee. 
  • The relationship of ovarian steroids, headache activity and menstrual distress: a pilot study with female migraineurs. 
  • The use of multiattribute decision models in evaluating triptan treatment options in migraine. 
  • Topiramate for the prophylaxis of episodic migraine in adults. 
  • Topiramate-induced confusion following a single ingestion of 400 mg. 
  • Toward evidence-based management of migraine. 
  • Treatment of migraine headache after ocular surgery with intravenous metoclopramide hydrochloride. 
  • Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults. 
  • WITHDRAWN: Oral sumatriptan for acute migraine. 
  • What are the diagnostic criteria for migraine-associated vertigo? 
  • When to stress over triptans: a Markov analysis of cardiovascular risk in migraine treatment.